{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:28:29Z","timestamp":1780378109810,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ctro.2021.12.001","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T20:51:19Z","timestamp":1642452679000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule"],"prefix":"10.1016","volume":"33","author":[{"given":"K.","family":"Smits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Dani\u00ebls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Neelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.det.2015.06.001","article-title":"Evaluation, diagnosis, and staging of cutaneous lymphoma","volume":"33","author":"Olsen","year":"2015","journal-title":"Dermatol Clin"},{"issue":"23","key":"10.1016\/j.ctro.2021.12.001_b0010","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"issue":"31","key":"10.1016\/j.ctro.2021.12.001_b0015","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2021.12.001_b0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"de Coninck","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2021.12.001_b0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0889-8588(03)00115-1","article-title":"Histopathology and genetics of cutaneous T-cell lymphoma","volume":"17","author":"Smoller","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.ctro.2021.12.001_b0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ctro.2021.12.001_b0035","doi-asserted-by":"crossref","unstructured":"Yamashita T, Abbade LP, Marques ME, Marques SA. Mycosis fungoides and Sezary syndrome: clinical, histopathological and immunohistochemical review and update. An Bras Dermatol. Nov-Dec 2012;87(6):817-28; quiz 829-30. doi:10.1590\/s0365-05962012000600001.","DOI":"10.1590\/S0365-05962012000600001"},{"issue":"12","key":"10.1016\/j.ctro.2021.12.001_b0040","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in nontransformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctro.2021.12.001_b0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome \u2013 Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.ctro.2021.12.001_b0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.2009.25.8301","article-title":"Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome","volume":"28","author":"Duvic","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0060","first-page":"623","article-title":"High energy electrons for the treatment of extensive superficial malignant lesions","volume":"69","author":"Trump","year":"1953","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.001_b0065","first-page":"292","article-title":"Electron beam therapy of mycosis fungoides","volume":"95","author":"Malcolm","year":"1961","journal-title":"Calif Med"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1148\/74.4.633","article-title":"A technique for large-field, superficial electron therapy","volume":"74","author":"Karzmark","year":"1960","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.001_b0075","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.001_b0080","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2013.04.042","article-title":"Results of a 5-week schedule of modern total skin electron beam radiation therapy","volume":"86","author":"Morris","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.001_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijrobp.2014.11.033","article-title":"Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique","volume":"92","author":"Heumann","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.001_b0090","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2018.09.02","article-title":"Total skin electron beam therapy in mycosis fungoides\u2014a shift towards lower dose?","volume":"8","author":"Chowdhary","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.001_b0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ctro.2021.12.001_b0100","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00066-017-1188-8","article-title":"Low-dose total skin electron beam therapy for cutaneous lymphoma: Minimal risk of acute toxicitiesNiedrigdosis-Ganzhautelektronenbestrahlung bei Patienten mit kutanen Lymphomen: Minimales Risiko f\u00fcr akute Toxizit\u00e4ten","volume":"193","author":"Kroeger","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.ctro.2021.12.001_b0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijrobp.2017.05.052","article-title":"The results of low-dose total skin electron beam radiation therapy (TSEB) in Patients with mycosis fungoides from the uk cutaneous lymphoma group","volume":"99","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0110","first-page":"625","article-title":"Radiation therapy in the management of cutaneous T-cell lymphomas","volume":"63","author":"Hoppe","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ctro.2021.12.001_b0115","doi-asserted-by":"crossref","unstructured":"Murrer L, Van der Hulst HP, Jansen W, et al. NCS Report 34: Code of Practice and Recommendations for Total Body Irradiation and Total Skin Irradiation. 2021.","DOI":"10.25030\/ncs-034"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.001_b0120","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2007.11.039","article-title":"A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides","volume":"71","author":"Kamstrup","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.001_b0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.001_b0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.001_b0135","doi-asserted-by":"crossref","unstructured":"Georgakopoulos I, Papadavid E, Platoni K, et al. Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12Gy) treatment schedule. Clin Transl Radiat Oncol. Feb 2019;15:26-30. doi:10.1016\/j.ctro.2018.12.002.","DOI":"10.1016\/j.ctro.2018.12.002"},{"issue":"8","key":"10.1016\/j.ctro.2021.12.001_b0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3109\/0284186X.2011.585999","article-title":"Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark","volume":"50","author":"Lindahl","year":"2011","journal-title":"Acta Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2021.12.001_b0145","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.clml.2016.08.019","article-title":"Total skin electron beam therapy in the treatment of mycosis fungoides: a review of conventional and low-dose regimens","volume":"16","author":"Chowdhary","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:32Z","timestamp":1762503032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":29,"alternative-id":["S2405630821001002"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.001","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}